✦ LIBER ✦

Low-dose cytosine arabinoside (Ara-C) therapy in the myelodysplastic syndromes and acute leukemia

✍ Scribed by Jane N. Winter; Daina Variakojis; Ellen R. Gaynor; Richard A. Larson; Kenneth B. Miller

Publisher: John Wiley and Sons
Year: 1985
Tongue: English
Weight: 664 KB
Volume: 56
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19850801)56:3<443::aid-cncr2820560305>3.0.co;2-q

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Low-dose cytosine arabinoside in the mye

Low-dose cytosine arabinoside in the myelodysplastic syndromes and acute myelogenous leukemia

✍ J. D. Roberts; W. B. Ershler; B. H. Tindle; J. A. Stewart 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 351 KB 👁 2 views

Seven patients with a myelodysplastic syndrome or "smoldering" acute myelogenous leukemia were treated with cytosine arabinoside in low dosage. Four patients experienced transient, partial responses characterized by improved peripheral blood counts, cessation of transfusion requirements, and a decre

Low-dose cytosine arabinoside in acute n

Low-dose cytosine arabinoside in acute non-lymphoblastic leukemia

✍ Lalit Kumar; V. Kochupillai; Harsch Dua 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 408 KB 👁 2 views

Low-dose arabinosyl cytosine in acute le

Low-dose arabinosyl cytosine in acute leukemia after a myelodysplastic syndrome and in elderly leukemia

✍ Emilio P. Alessandrino; Ester Orlandi; Ercole Brusamolino; Mario Lazzarino; Carl 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 190 KB 👁 2 views

The role of low-dose cytosine arabinosid

The role of low-dose cytosine arabinoside and aggressive chemotherapy in advanced myelodysplastic syndromes

✍ Carlo Aul; Wolfgang Schneider 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 704 KB

Low-dose cytosine arabinoside for treati

Low-dose cytosine arabinoside for treating hypocellular acute leukemia in the elderly

✍ Heiwa Kanamori; Dr. Atsuo Maruta; Hiroko Miyashita; Hiroshi Harano; Hitoshi Fuka 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 403 KB 👁 2 views

High dose cytosine arabinoside (HDARAC)

High dose cytosine arabinoside (HDARAC) in refractory acute leukemia

✍ Seth A. Rudnick; Edwin C. Cadman; Robert L. Capizzi; Roland T. Skeel; Joseph R. 📂 Article 📅 1979 🏛 John Wiley and Sons 🌐 English ⚖ 415 KB 👁 2 views

Thirteen leukemic patients with disease refractory to conventional chemotherapy were treated with 1.0 to 7.5 g/m2 of Cytosine Arabinoside (Ara-C) over 29 drug cycles. Drug infusions were spaced at 12-hour intervals; a maximum of four doses was administered over 36 hours. After single dose tolerance